Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeen Regulatory News (SEEN)

Share Price Information for Seeen (SEEN)

Share Price is delayed by 15 minutes
Get Live Data
4.50    0.00 (0.00%)
Bid:
4.00
Ask:
5.00
Spread: 1.00 (25.00%)
Market Cap: £6.39m
SEEN Live PriceLast checked at - London Stock Exchange

Intraday Seeen Share Chart

Subscription

17 Jul 2024 07:00

RNS Number : 6647W
SEEEN PLC
17 July 2024
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 WHICH HAS BEEN INCORPORATED INTO UK LAW BY THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

17 July 2024

 

SEEEN plc

("SEEEN" or the "Company")

Subscription for new Ordinary Shares to raise £45,000

 

Total voting rights

 

SEEEN plc (AIM: SEEN), the global media and technology platform that delivers Key Video Moments to drive Video Commerce and transform its clients' video profitability, announces that further to the Fundraise announced on 31 May 2024, it has raised a further £45,000 on the same terms as those of the Fundraise from certain existing investors who were unable to participate in the Fundraise.  

 

Utilising the Directors' existing authorities given by Shareholders to issue new ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") for cash on a non-pre-emptive basis, the Company has raised gross proceeds of £45,000 through a subscription, and the allotment and issue by the Company (subject to Admission, as defined below) of 1,500,000 new Ordinary Shares (the "Subscription Shares") at an issue price of 3 pence per Subscription Share (the "Subscription"). Each investor will also receive one Warrant for every one Subscription Share subscribed for pursuant to the Subscription, with each Warrant entitling the holder to acquire one new Ordinary Share at a price of 4.5 pence at any time prior to 19 June 2026. The net proceeds of the Subscription will be used for working capital purposes.

 

Application for Admission

 

Application has been made for the Subscription Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and that dealings will commence at 8.00 a.m. on or around 19 July 2024. Once issued, the Subscription Shares will rank pari passu with the Company's existing Ordinary Shares.

 

Total voting rights

 

Following Admission, the enlarged issued share capital of the Company will comprise 120,279,141 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Consequently, following Admission, 120,279,141 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Significant shareholding

 

The Company is aware of the following significant shareholder in the Company (as defined in the AIM Rules for Companies), whose percentage interest in the enlarged share capital will be revised following Admission and the issue of the Subscription Shares:

 

Name

Number of Ordinary Shares held

Percentage of enlarged share capital following Admission

Water Intelligence plc

5,938,366

4.94%

 

 

Unless otherwise stated, capitalised terms not otherwise defined in the text of this announcement have the same meanings ascribed to them as in the "Placing and Subscription and other matters" announcement published by the Company on 31 May 2024.

 

For further information please contact:

SEEEN plc

Tel: +44 (0)7775 701 838

Adrian Hargrave, Chief Executive Officer

Dowgate Capital Limited - Joint Broker

Tel: +44 (0)20 3903 7715

Stephen Norcross

Capital Plus Partners Limited - Joint Broker

Tel: +44 (0)20 3821 6167

Jonathan Critchley / Jon Levinson

 

Allenby Capital Limited - Nominated Adviser and Joint Broker

Tel: +44 (0)20 3328 5656

Alex Brearley / George Payne / Lauren Wright (Corporate Finance)

Tony Quirke / Amrit Nahal (Sales and Corporate Broking)

focusIR - Investor Relations

Tel: +44 (0)20 4570 2234

Paul Cornelius / Kat Perez

email: seeen@focusir.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUNRKRSVUBAAR
Date   Source Headline
24th Jun 20243:23 pmRNSHolding(s) in Company
20th Jun 20244:22 pmRNSHolding(s) in Company
17th Jun 202412:55 pmRNSResult of General Meeting and Total Voting Rights
7th Jun 202412:23 pmRNSHolding(s) in Company
5th Jun 20248:30 amRNSAdmission of First Fundraise Shares
31st May 20247:00 amRNSPlacing and Subscription and other matters
1st Mar 20247:00 amRNSPartnership with the American 7s Football League
2nd Feb 20247:00 amRNSDirector dealings
1st Feb 20247:00 amRNSTrading Update and Board Change
18th Jan 20247:00 amRNSPartnership with the London Broncos
29th Sep 20237:00 amRNSInterim Results
26th Sep 202311:57 amRNSHolding(s) in Company
6th Sep 20237:00 amRNSTechnology Day
24th Aug 20237:00 amRNSDirector dealing
26th Jul 202312:23 pmRNSResult of AGM
26th Jul 20237:00 amRNSLaunch of CreatorSuite 2.0
30th Jun 20237:00 amRNSResults for the year ended 31 December 2022
7th Jun 20237:00 amRNSAttendance at UK Investor Show
18th May 20237:00 amRNSAppointment of Non-Executive Director and CFO
6th Feb 20237:00 amRNSTrading Update, Customer Win and Board Change
11th Jan 202312:22 pmRNSHolding(s) in Company
4th Jan 20231:15 pmRNSHolding(s) in Company
30th Dec 20221:00 pmRNSTotal Voting Rights
28th Dec 20227:00 amRNSHolding(s) in Company
28th Dec 20227:00 amRNSHolding(s) in Company
23rd Dec 20229:44 amRNSResult of GM and Open Offer
7th Dec 20226:25 pmRNSFundraise and other matters
7th Dec 20226:22 pmRNSAppointment of Nominated Adviser and Joint Broker
8th Nov 20225:27 pmRNSHolding(s) in Company
28th Oct 20225:13 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSInterim Results
26th Aug 20225:07 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20224:59 pmRNSResult of AGM
11th Jul 20227:01 amRNSCustomer Win - Daily Mail
11th Jul 20227:00 amRNSCEO Appointment
6th Jul 20227:00 amRNSCustomer Wins
30th Jun 20227:00 amRNSFinal Results and Notice of AGM
31st May 20227:00 amRNSDirector Shareholding and Notice of Results
31st May 20227:00 amRNSHolding(s) in Company
27th May 20227:00 amRNSBoard Appointment Confirmation
25th Apr 20224:41 pmRNSSecond Price Monitoring Extn
25th Apr 20224:36 pmRNSPrice Monitoring Extension
7th Apr 20227:00 amRNSContract Wins
16th Mar 20227:00 amRNSDirector Changes, Business Update
23rd Feb 20227:00 amRNSStrategic Partnership with Kinetiq, Inc
3rd Feb 20227:00 amRNSTrading Update
27th Jan 20227:00 amRNSContract Wins and Notice of Trading Update
2nd Dec 20217:00 amRNSContract Wins and 3Q Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.